ALS-associated protein FIG4 is localized in Pick and Lewy bodies, and also neuronal nuclear inclusions, in polyglutamine and intranuclear inclusion body diseases

Neuropathology

Volumn 34, Issue 1, 2014, Pages 19-26

  Kon, Tomoya ^a   Mori, Fumiaki ^a   Tanji, Kunikazu ^a   Miki, Yasuo ^a   Toyoshima, Yasuko ^b   Yoshida, Mari ^d   Sasaki, Hidenao ^e   Kakita, Akiyoshi ^c   Takahashi, Hitoshi ^b   Wakabayashi, Koichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Department of Pathology   (India)

^c NIIGATA UNIVERSITY   (Japan)

^d AICHI MEDICAL UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Endosomal lysosomal pathway; FIG4; Lewy body; Nuclear inclusion; Pick body

Indexed keywords

ALPHA SYNUCLEIN; FIG4 PROTEIN; PHOSPHATASE; POLYGLUTAMINE; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOPSY; BASAL GANGLION; BRAIN; BRAIN CORTEX; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DENTATORUBROPALLIDOLUYSIAN ATROPHY; DIFFUSE LEWY BODY DISEASE; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; MAJOR CLINICAL STUDY; MIDDLE AGED; PARKINSON DISEASE; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN LOCALIZATION; SHY DRAGER SYNDROME; SPINAL CORD; SUBSTANTIA NIGRA; TDP 43 PROTEINOPATHY;

ENDOSOMAL-LYSOSOMAL PATHWAY; FIG4; LEWY BODY; NUCLEAR INCLUSION; PICK BODY;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; FLAVOPROTEINS; HUMANS; INTRANUCLEAR INCLUSION BODIES; LEWY BODIES; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEURONS; PEPTIDES; PHOSPHORIC MONOESTER HYDROLASES; PICK DISEASE OF THE BRAIN;

EID: 84892802771     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12056     Document Type: Article

References (44)

1. Nagase T, Seki N, Ishikawa K etal. Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain. DNA Res 1996; 3: 321-329.
2. Erdman S, Lin L, Malczynski M, Snyder M. Pheromone-regulated genes required for yeast mating differentiation. J Cell Biol 1998; 140: 461-483.
3. Winters JJ, Ferguson CJ, Lenk GM etal. Congenital CNS hypomyelination in the Fig4 null mouse is rescued by neuronal expression of the PI(3, 5)P phosphatase Fig4. J Neurosci 2011; 31: 17736-17751.
4. Guo J, Ma YH, Yan Q etal. Fig4 expression in the rodent nervous system and its potential role in preventing abnormal lysosomal accumulation. J Neuropathol Exp Neurol 2012; 71: 28-39.
5. Ferguson CJ, Lenk GM, Jones JM etal. Neuronal expression of Fig4 is both necessary and sufficient to prevent spongiform neurodegeneration. Hum Mol Genet 2012; 21: 3525-3534.
6. Chow CY, Zhang Y, Dowling JJ etal. Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 2007; 448: 68-72.
7. Zhang X, Chow CY, Sahenk Z, Shy ME, Meisler MH, Li J. Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. Brain 2008; 131: 1990-2001.
8. Chow CY, Landers JE, Bergren SK etal. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet 2009; 84: 85-88.
9. Takalo M, Salminen A, Soininen H, Hiltunen M, Haapasalo A. Protein aggregation and degradation mechanisms in neurodegenerative diseases. Am J Neurodegener Dis 2013; 2: 1-14.
10. Martinez-Vicente M, Cuervo AM. Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 2007; 6: 352-361.
11. Arai T, Mackenzie IR, Hasegawa M etal. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 2009; 117: 125-136.
12. Tan C-F, Yamada M, Toyoshima Y etal. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease. Acta Neuropathol 2009; 118: 553-560.
13. Toyoshima Y, Tanaka H, Shimohata M etal. Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology. Acta Neuropathol 2011; 122: 375-378.
14. Blokhuis AM, Groen EJN, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 2013; 125: 777-794.
15. Woulfe J, Gray DA, Mackenzie IR. FUS-immunoreactive intranuclear inclusions in neurodegenerative disease. Brain Pathol 2010; 20: 589-597.
16. Mori F, Tanji K, Kon T etal. FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease. Neuropathol Appl Neurobiol 2012; 38: 322-328.
17. Osawa T, Mizuno Y, Fujita Y, Takatama M, Nakazato Y, Okamoto K. Optineurin in neurodegenerative diseases. Neuropathology 2011; 31: 569-574.
18. Mori F, Tanji K, Toyoshima Y etal. Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington's, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease. Acta Neuropathol 2012; 123: 747-749.
19. Brettschneider J, Van Deerlin VM, Robinson JL etal. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta Neuropathol 2012; 123: 825-839.
20. Mori F, Tanji K, Odagiri S etal. Ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease. Acta Neuropathol 2012; 124: 149-151.
21. Tanikawa S, Mori F, Tanji K, Kakita A, Takahashi H, Wakabayashi K. Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy. Neurosci Lett 2012; 527: 16-21.
22. Kurashige T, Takahashi T, Yamazaki Y etal. Localization of CHMP2B-immunoreactivity in the brainstem of Lewy body disease. Neuropathology 2013; 33: 237-245.
23. Mori F, Tanji K, Toyoshima Y etal. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease. Neuropathology 2013; 33: 637-644.
24. Mackenzie IR, Neumann M, Baborie A etal. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 2011; 122: 111-113.
25. Wakabayashi K, Hayashi S, Kakita A etal. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol 1998; 96: 445-452.
26. Nishie M, Mori F, Fujiwara H etal. Accumulation of phosphorylated α-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy. Acta Neuropathol 2004; 107: 292-298.
27. Oyanagi S, Tanaka M, Omori T, Matsushita M, Ishii T. Regular arrangements of tubular structures in Pick bodies formed in an autopsied case of Pick's disease (in Japanese with English abstract). Shinkei Simpo 1979; 23: 441-451.
28. Oyanagi S. A Guide to Neuropathology by Electron Microscopy, 1st edn. Tokyo: Igaku Shoin, 1992.
29. Mori F, Hayashi S, Yamagishi S etal. Pick's disease: α- and β-synuclein-immunoreactive Pick bodies in the dentate gyrus. Acta Neuropathol 2002; 104: 455-461.
30. Duffy PE, Tennyson VM. Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson's disease. J Neuropathol Exp Neurol 1965; 24: 398-414.
31. Jones AL, Quimby BB, Hood JK etal. SAC3 may link nuclear protein export to cell cycle progression. Proc Natl Acad Sci USA 2000; 97: 3224-3229.
32. Takahashi T, Katada S, Onodera O. Polyglutamine diseases: where does toxicity come from? What is toxicity? Where are we going? J Mol Cell Biol 2010; 2: 180-191.
33. Beach TG, Walker DG, Sue LL, Newell A, Adler CC, Joyce JN. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers. J Neuropathol Exp Neurol 2004; 63: 329-337.
34. Ikeda K. A study of the Marinesco body in monkey (Macaca fuscata). A comparative study to the Marinesco body in man (in Japanese with English abstract). Seishin Shinkeigaku Zasshi 1974; 76: 778-792.
35. Odagiri S, Tanji K, Mori F etal. Immunohistochemical analysis of Marinesco bodies, using antibodies against proteins implicated in the ubiquitin-proteasome system, autophagy and aggresome formation. Neuropathology 2012; 32: 261-266.
36. Suzuki K, Ohsumi Y. Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae. FEBS Lett 2007; 581: 2156-2161.
37. Volpicelli-Daley L, De Camilli P. Phosphoinositides link to neurodegeneration. Nat Med 2007; 13: 784-786.
38. Lázaro-Diéguez F, Knecht E, Egea G. Clearance of a Hirano body-like F-actin aggresome generated by jasplakinolide. Autophagy 2008; 4: 717-720.
39. Satoh J, Tabunoki H, Ishida T, Saito Y, Arima K. Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neuritis in Alzhermer's disease brains. Neuropathol Appl Neurobiol 2013. doi: 10.1111/nan.12036
40. Heir R, Ablasou C, Dumontier E, Elliott M, Fagotto-Kaufmann C, Bedford FK. The UBL domain of PLIC-1 regulates aggresome formation. EMBO Rep 2006; 7: 1252-1258.
41. Viswanathan J, Haapasalo A, Böttcher C etal. Alzheimer's disease-associated ubiquilin-1 regulates presenilin-1 accumulation and aggresome formation. Traffic 2011; 12: 330-348.
42. Rothenberg C, Srinivasan D, Mah L etal. Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Hum Mol Genet 2010; 19: 3219-3232.
43. Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011; 7: 279-296.
44. N'Diaye EN, Kajihara KK, Hsieh I, Morisaki H, Debnath J, Brown EJ. PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. EMBO Rep 2009; 10: 173-179.